BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• 

  Drug Development

  Roche Halts Colorectal Cancer Trial Recruitment After 4 Patient Deaths

  Roche announced it had temporarily halted recruiting patients to its Phase II MODUL clinical trial for metastatic colorectal cancer after four patient deaths. The patients were receiving Tecentriq (atezolizumab) in combination with Exelixis’ MEK inhibitor Cotellic (cobimetinib).

  April 11, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  UPDATED: Theranos Slashes 100 Employees, Possible Shut Down in July

  Storm-tossed Theranos continues to get battered from the continued fallout from the myriad of self-inflicted problems it has faced over the past few years. Now the company has reportedly laid off an additional 100 employees as it strives to avoid shutting down from bankruptcy.

  April 11, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  After Trial Failure, Pfizer’s Inlyta Unlikely to Replace Sutent for Kidney Cancer

  An Independent Monitoring Committee recommended that Pfizer halt the Phase III ATLAS trial of Inlyta (axitinib) because it wasn’t proving effective.

  April 11, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Alexion Purchases Wilson Therapeutics for $855M: Expands Pipeline

  Alexion Pharmaceuticals is buying Wilson Therapeutics for $855 million. With the company, Alexion will acquire WTX101, Wilson Therapeutics’ Phase III compound for Wilson disease.

  April 11, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Pushes Back PDUFA Date for AbbVie’s Endometriosis Drug

  The U.S. Food and Drug Administration wants more time to review AbbVie’s elagolix, a treatment for endometriosis-associated pain.

  April 11, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  CVS Unveils Tool: Will the Pharma Industry Respond?

  The retail price of prescription drugs is a concern for many people in the United States. Now CVS is attempting to disrupt the retail end of things with a new savings finder tool.

  April 11, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Cellectis Snags $164 Million in IPO to Advance CAR-T Programs

  Cellectis has found some sure financial footing that will support its efforts through the remainder of the year. The company secured $163.7 million in an initial public offering to develop CART-T products.

  April 11, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Pipeline Concerns: Four Biotechs to Keep Your Eye On

  When a pipe in someone’s house breaks or leaks it can cause a lot of damage to the property if it is not addressed in a timely manner. The same can be said for the pipelines of biopharma companies.

  April 11, 2018

   · 

  3 min read

   · 

  Alex Keown
• Deals

  Alexion to Acquire Wilson Therapeutics

  Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare copper-mediated disorders.

  April 11, 2018

   · 

  10 min read
• Business

  Evotec Forms Collaboration with Petra Pharma on Indigo Platform

  Petra Pharma to harness Evotec’s indigo platform to accelerate its lead programme through IND filing.

  April 11, 2018

   · 

  5 min read